Quadrant Capital Group LLC Wave Life Sciences Ltd. Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,396 shares of WVE stock, worth $32,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,396
Previous 2,396
-0.0%
Holding current value
$32,130
Previous $11,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$244 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$135 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$130 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$90.4 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$82.7 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.16B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...